https://doi.org/10.4081/monaldi.2023.2741
SARS-CoV-2 pneumonia and Eisenmenger’s Syndrome: doubling the challenge
Submitted: August 5, 2023
Accepted: October 23, 2023
Published: November 6, 2023
Accepted: October 23, 2023
Abstract Views: 379
PDF_early view: 227
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Eisenmenger’s syndrome (ES) is the most severe phenotype of pulmonary arterial hypertension (PAH) secondary to congenital heart disease. In these cases, a significant systemic-to-pulmonary (left-to-right) shunting triggers the development of pulmonary vascular disease (PVD) and pulmonary hypertension. In cases of acute hypoxemic respiratory failure in patients with ES, high flow nasal cannula (HFNC) oxygen therapy should be considered as a first-line approach in order to avoid pulmonary complications and right ventricular overload related to positive pressure ventilation. Here, we report a case of HFNC use in a patient with COVID-19 infection and ES.
Nashat H, Kempny A, McCabe C, et al. Eisenmenger syndrome: current perspectives. Res Rep Clinl Cardiol 2017;8:1-12.
DOI: https://doi.org/10.2147/RRCC.S117838
Buonamico E, Quaranta VN, Boniello E, et al. Risk factors for transfer from Respiratory Intermediate Care Unit to Intensive Care Unit in COVID-19. Respir Investig 2021;59:602-7.
DOI: https://doi.org/10.1016/j.resinv.2021.05.002
Ippolito M, Simone B, Filisina C, et al. Bloodstream infections in hospitalized patients with COVID-19: a systematic review and meta-analysis. Microorganisms 2021;9:2016.
DOI: https://doi.org/10.3390/microorganisms9102016
Crimi C, Noto A, Cortegiani A, et al. Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections. Minerva Anestesiol 2020;86:1190-204.
DOI: https://doi.org/10.23736/S0375-9393.20.14785-0
Racca F, Appendini L, Berta G, et al. Helmet ventilation for acute respiratory failure and nasal skin breakdown in neuromuscular disorders. Anesth Analg 2009;109:164-7.
DOI: https://doi.org/10.1213/ane.0b013e3181a1f708
Pierucci P, Ambrosino N, Di Lecce V, et al. Prolonged active prone positioning in spontaneously breathing non-intubated patients with COVID-19-associated hypoxemic acute respiratory failure with PaO2/FiO2>150. Front Med (Lausanne) 2021;8:626321.
DOI: https://doi.org/10.3389/fmed.2021.626321
Vega ML, Dongilli R Olaizola G, et al. COVID-19 pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU. Pulmonology 2022;28:13-7.
DOI: https://doi.org/10.1016/j.pulmoe.2021.04.003
Carpagnano GE, Pierucci P, Migliore G, et al. Tailored post-acute care coordination for survivors of moderate to severe COVID-19 infection. J Am Med Dir Assoc 2022;23:447-9.
DOI: https://doi.org/10.1016/j.jamda.2021.12.014
Walker F, Mullen MJ, Woods SJ, Webb GD. Acute effects of 40% oxygen supplementation in adults with cyanotic congenital heart disease. Heart 2004;901073-4.
DOI: https://doi.org/10.1136/hrt.2002.000299
Pierucci P, Portacci A, Carpagnano GE, et al. The right interface for the right patient in noninvasive ventilation: a systematic review. Expert Rev Respir Med 2022;16:931-44.
DOI: https://doi.org/10.1080/17476348.2022.2121706
Oczkowski S, Ergan B, Bos L, et al. ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J 2022;59:2101574.
DOI: https://doi.org/10.1183/13993003.01574-2021
Misseri G, Pierucci P, Bellina D, et al. Early pronation, protective lung ventilation and use of awake-prone-HFNO therapy after extubation in near-fatal drowning. Pulmonology 2023:S2531-0437(23)00010-7. Online Ahead of Print.
DOI: https://doi.org/10.1016/j.pulmoe.2022.12.006
How to Cite
Pierucci, Paola, Lucrezia De Michele, Maria Luisa de Candia, Federica Barratta, Cesare Gregoretti, Giovanna Elisiana Carpagnano, and Giovanni Misseri. 2023. “SARS-CoV-2 Pneumonia and Eisenmenger’s Syndrome: Doubling the Challenge”. Monaldi Archives for Chest Disease, November. https://doi.org/10.4081/monaldi.2023.2741.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Vinnie Sarah Ch Sangma, Surabhi Jaggi, Varinder Saini, Deepak Aggarwal, Pankaj Kumar, Jagdish Chander, Prevalence of latent tuberculosis infection in household contacts of pulmonary tuberculosis, time to treat , Monaldi Archives for Chest Disease: Vol. 94 No. 1 (2024)
- Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria, Tocilizumab for COVID-19: A systematic review and meta-analysis of randomized controlled trials , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- T. Berghmans, A-P Meert, V. Ninane, J-P Sculier, Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study , Monaldi Archives for Chest Disease: Vol. 63 No. 4 (2005): Pulmonary series
- K. Katsoulis, T. Kontakiotis, S. Gerou, M. Kougioulis, H. Lithoxopoulou, D. Papakosta, Alterations of Erythrocyte Superoxide Dismutase activity in patients suffering from asthma attacks , Monaldi Archives for Chest Disease: Vol. 73 No. 3 (2010): Pulmonary series
- A.J. Lopes, T.T. Mafort, A. de Sá Ferreira, M.C. Santos de Castro, M. de Cássia Firmida, E. de Andrade Marques, Is the type of chronic pulmonary infection a determinant of lung function outcomes in adult patients with cystic fibrosis? , Monaldi Archives for Chest Disease: Vol. 77 No. 3-4 (2012): Pulmonary series
- Raffaele Griffo, Marco Ambrosetti, Giuseppe Furgi, Roberto Carlon, Carmine Chieffo, Giuseppe Favretto, Oreste Febo, Ugo Corrà , Francesco Fattirolli, Pantaleo Giannuzzi, Cesare Greco, Massimo F. Piepoli, Pier Luigi Temporelli, Roberto Tramarin, Stefano Urbinati, Standards and outcome measures in Cardiovascular Rehabilitation. Position Paper GICR/IACPR , Monaldi Archives for Chest Disease: Vol. 78 No. 4 (2012): Cardiac series
- Bruno Bordoni, Fabiola Marelli, Bruno Morabito, Beatrice Sacconi, Depression, anxiety and chronic pain in patients with chronic obstructive pulmonary disease: the influence of breath , Monaldi Archives for Chest Disease: Vol. 87 No. 1 (2017)
- Halil Yanardag, Cuneyt Tetikkurt, Muammer Bilir, Erkan Yılmaz, Association of HLA antigens with the clinical course of sarcoidosis and familial disease , Monaldi Archives for Chest Disease: Vol. 87 No. 3 (2017)
- C. Incorvaia, C. Pravettoni, M. Mauro, M.-R. Yacoub, F. Tarantini, G.G. Riario-Sforza, Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis , Monaldi Archives for Chest Disease: Vol. 69 No. 2 (2008): Pulmonary series
- Kashyap Goyal, Subodh Kumar, Mayank Mishra, Ritisha Bhatt, Adabala Vijay Babu, Mukesh Tripathi, A malignant wheeze! , Monaldi Archives for Chest Disease: Vol. 88 No. 3 (2018)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
You may also start an advanced similarity search for this article.
